Drugs Flashcards
Carbidopa
Dopamine Decarboxylase inhibitor Blocks decarboxylase in the intestine and peripheral organs Doesn't cross BBB Reduces amt of L-DOPA needed Drug for Parkinson's
Levodopa/Carbidopa
Combo often given
Dopamine Precursor/DDC inhibitor
Drug for Parkinson’s
Pramipexole
Dopamine Receptor Agonist (D2 and D3)
Drug for Parkinson’s
Usually not a replacement for L-DOPA/Carbidopa
Ropinirole
Dopamine Receptor Agonist (D2)
Drug for Parkinson’s
Usually not a replacement for L-DOPA/Carbidopa
Amantadine
Dopamine Releaser-NMDA block
Facilitate the release of endogenous dopamine
Drug for Parkinson’s
Kinds of drugs used to treat Parkinson’s
Dopamine Precursors / DDC inhibitors
Dopamine Receptor Agonists
Dopamine Releaser-NMDA block
Anticholinergic Drugs
Monoamine Oxidase Inhibitors (prevent DA breakdown)
Catechol-O-Methyltransferase Inhibitors (prevent DA breakdown)
Drugs used in the treatment of glaucoma
Prostaglandin analogs, Alpha-2 adrenergic agonists, Beta-adrenergic antagonists, Carbonic anhydrase inhibitors, Cholinergic Receptor Agonists
Drugs for Tourette’s syndrome
tetrabenazine, neuroleptics-aka dopamine receptor antagonis
Drugs for essential tremor
primidone, propranolol
Drugs for Huntington’s
tetrabenazine, neuroleptics-aka dopamine receptor antagonist (haloperidol)
Prostaglandin analogs
Treatment of Glaucoma
Increase outflow of aqueous humor (Decr IOP)
First line medical therapy as part of stepped approach
Alpha-2 adrenergic agonists
Treatment of Glaucoma
Can be used as add-on second- or third-line therapy
Increases uveoscleral outflow of aqueous humor and inhibits the formation of aqueous humor
Beta-adrenergic antagonists
Treatment of Glaucoma
Next most common medical treatment after prostaglandin analogs
Reduce production of aqueous humor (decreased aqueous secretion from ciliary epithelium)
Carbonic anhydrase inhibitors
Treatment of Glaucoma
Can be used as add-on second- or third-line therapy.
Inhibition of carbonic anhydrase in the ciliary body epithelium reduces formation of bicarbonate ions which reduces fluid transport and IOP
Cholinergic Receptor Agonists
Treatment of Glaucoma
Historically important in glaucoma treatment but less commonly used today
Lower IOP by causing muscarinic receptor-induced contraction of ciliary muscle which facilitates aqueous outflow